Related Experiment Video
Updated: Jun 20, 2025
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
19.9K
Why making smoking cessation a priority for rare interstitial lung disease smokers?
Cristina Vicol1, Raluca Ioana Arcana1,2, Antigona Carmen Trofor1,2
1University of Medicine and Pharmacy "Grigore T. Popa", Iaşi, Romania.
Tobacco Prevention & Cessation
|July 17, 2024
Summary
Smoking significantly worsens interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF). Tailored smoking cessation programs are crucial for improving outcomes in these vulnerable patients.
Area of Science:
- Pulmonology
- Toxicology
- Public Health
Background:
- Interstitial lung diseases (ILDs) are a group of debilitating lung conditions with significant morbidity and mortality.
- Cigarette smoking is a major modifiable risk factor contributing to the development and progression of various ILDs.
- Specific ILDs strongly associated with smoking include idiopathic pulmonary fibrosis (IPF), respiratory bronchiolitis-associated ILD (RB-ILD), and desquamative interstitial pneumonia (DIP).
Purpose of the Study:
- To review the intricate relationship between smoking and interstitial lung diseases.
- To highlight the role of smoking in the pathogenesis and progression of ILDs.
- To explore personalized smoking cessation strategies for patients with ILDs.
Main Methods:
- This is a narrative review synthesizing existing epidemiological and clinical data.
- Literature search focused on studies examining smoking as a risk factor for ILDs.
- Analysis of challenges and success factors in smoking cessation for ILD patients.
Main Results:
- Epidemiological evidence consistently links smoking to increased risk and severity of ILDs like IPF, RB-ILD, and DIP.
- Smoking cessation offers established benefits for patients with ILDs.
- Current smoking cessation programs show modest success rates in ILD patients due to factors like nicotine addiction and psychological influences.
Conclusions:
- Cigarette smoking is a critical factor in the development and progression of interstitial lung diseases.
- Effective smoking cessation is paramount for managing ILDs.
- Tailored interventions and sustained support are essential to overcome barriers and enhance smoking cessation success in patients with ILDs.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
194
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
194
01:20COPD: Pathogenesis and Clinical Features
252
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
252
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.8K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.8K